Gland Pharma Limited IPO Message Board (Page 16)

Gland Pharma IPO

LAST Day at 1:45PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 03.24X (*Excluding Anchor)
NII: 0.10X
RII: 00.19X
Total: 1.04X

*RII Applications: 1.65L* Approx
No. of Applic-wise: 00.11X


Gland Pharma IPO
GMP 18 +/- 1

NII subscription is low, ipo is getting risky...

Actually NIIs are the one who sell on listing day. So the risk is reducing

WHAT IS CLOSING TIME OF BIDDING UNDER ASBA ?

NII 3 PM. Retail 5PM

Depends on your Bank. SBI always closes at 2 PM. HDFC by 4 PM. Different banks has different closure times.

Just put up application for 14 lots

Gland Pharma IPO

LAST Day at 1:35PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 03.06X (*Excluding Anchor)
NII: 0.10X
RII: 00.19X
Total: 0.99X

Gland Pharma IPO
GMP 18 +/- 1

Retailers are smarter than QIB
Also HNI are enjoing Diwali , rather than increasing blood pressure in Diwali period

Happy Diwali to you sir.

Yes, You are right only smart retailers are investing in Gland.
I remember HDFC life as well as Interglobe aviation RII portion was undersubscribed.

This is an indian co, Fosun invested over billion US$ and cashing part of it now.
2017 valuations of company (revenue/EPS) etc are not comparable to 2020.
Fosun is now giving you a chance to buy back some shares.

As for China connection > If you use that most ppl would have to throw away smart phones, TVs/Laptop screens (most panels are made in china), Solar panels, compressors from your ACs/Fridges etc etc and many more pharma products as well.

I dont think smart retailers and NIIs will sell at loss, QIBs remain to be seen.

Have a great diwali

Word HNI associated with blood pressure.So atleast two lac investment considered.

Dear Admin
Messages Showing One hour time difference.

Gland Pharma Subscription Finally 1X

Why subscription numbers are not getting updated for every 10 mins on this forum page..??

At 10.35 AM issue subscribed 69%. QIB 2.1 time. Retail 16% with 1.42 lakh applications.
How many mutual funds have shut down as they failed to perform. So QIBs need to show performance for continuity and track record.

Reading your arguments since last 4 days. what a support you are providing to this company. Carry on, there should always diverse view in a discussion and you are providing other side of the view.

Managers of fund houses are not pumping their money. It is public money. They are least bothered. I think they get something from backdoor to invest in such issues aggressively. For example if you look at IPO of HAL which is a public sector company, Financial institutions thought of not investing as it is aggressively priced and they stayed away from it. Ultimately government of India asked LIC to step in which bought some major stake and made the IPO sail safely.
For private sector companies there will be some tie-up otherwise how they will aggressively invest although it has overprice concerns + geo political concerns and every one is aware that it will list at low price than the listing price.

Gland Pharma IPO

LAST Day at 1:05PM

The following data is assuming the shares will be issued at @1500/- (upper price band)

QIB*: 03.05X (*Excluding Anchor)
NII: 0.09X
RII: 00.18X
Total: 0.98X

*RII Applications: 160L* Approx
No. of Applic-wise: 00.11X

98% SUBSCRIBE

LATEST BIDDIND DETAILS, PLEASE

issue fully subscribed at 1 PM, in QIB most of bids are from FIIs category.

.

Gland Pharma IPO – Schedule *(FINAL – Pg #291 of RHP)*

04th Nov – Announcement of Price Band
06th Nov – Anchor Investors Allotment
09th Nov – Offer Opens
11th Nov – Offer Closes
17th Nov – Finalisation of Basis of Allotment
18th Nov – Unblocking of ASBA Accounts
19th Nov – Credit of Equity Shares to Depository Accounts
20th Nov – Commencement of Trading


Gland Pharma IPO – Issue Information *(FINAL)*

Issue Opens on: 09 November 2020
Issue Closes on: 11 November 2020
Issue Type: Book Built Issue IPO
Issue Size: 4,31,96,968 Shares
Face Value: Rs.1/- per Share
Issue Price: Rs.1,490 – Rs.1,500 per Share *(FINAL)*
Discount: NIL
Market Lot: 10 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 15,49,49,490 Shares
Fresh Issue of Shares 83,33,333 @1,500/- = Rs.1,250.00Crs
Offer for Sale of 3,48,63,635 Shares @1,500/- = Rs.5,229,55Crs
Equity Shares outstanding after the Issue = 16,32,82,823 Shares

Category-wise Break up:
Anchor – 1,29,59,090 Shares = 1,943.86Crs
QIB – 86,39,394 Shares = 1,295.91Crs
NII – 64,79,545 Shares = 971.93Crs
RII – 1,51,18,939 Shares = 2,267.84Crs (Lot size:10 = 15,11,894 Forms)
Total Issue – 4,31,96,968 Shares = 6,479.55Crs.

Subscription required for 1X
RII = 15,11,894 Forms
NII = 971.93 Crs


Gland Pharma IPO – Financial Information (Basis of Valuation)
The information is collated from the following documents:
1) RHP = Red Herring Prospectus dated October 31, 2020 (333 pages)

EPS for FY17-18 >>> Rs.20.72 (Page #86 of RHP)
EPS for FY18-19 >>> Rs.29.16 (Page #86 of RHP)
EPS for FY19-20 >>> Rs.49.88 (Page #86 of RHP)
EPS for Q120-21 >>> Rs.20.24 (Page #86 of RHP)

RoNW for FY17-18 >>> 13.32% (Page #87 of RHP)
RoNW for FY18-19 >>> 15.79% (Page #87 of RHP)
RoNW for FY19-20 >>> 21.20% (Page #87 of RHP)
RoNW for Q120-21 >>> 07.91% (Page #87 of RHP)

NAV as on June 30, 2020 was Rs.255.79 (Page #87 of RHP)

According to the IQVIA Report, principal competitors include (Page #33 of RHP):
Recipharm AB, Catalent, Inc., Lonza Group AG, Piramal Pharma Solutions


Gland Pharma IPO – *Market’s Current Estimates of oversubscription*:

NII = 18.50K Crs. = ~19.03X
RII = 15.12L Forms = 1.00X Applic. wise (Avg allotment of ~10.00 shares per lot)

Interest cost *@5.50%p.a.* for 7days = 158.22paise for 1X

Thus, for NII the costing = 19.03 X 158.22paise = Rs.30.12 per share (= GMP)

And, for RII the costing = 10.00 X 30.12 = Rs.301/- (= Kostak)


Gland Pharma IPO – *GMP Estimated*

GMP 30 +/- 2
Kostak 300 +/- 25

Hello Mam,
In other site they say the GMP is fall.
Is it worth to invest in the same.
Do you have any group for the same. If yes than how can I join you.

What is current oversubscription estimate of market .
if available please share.

Shares of Gland pharma will be available at 10-15% discount after Diwali as festive discount so be ready HAPPY DIWALI TO YOU ALL

Gland Pharma IPO

LAST Day at 12:05PM

The following data is assuming the shares will be issued at @1500/- (upper price band)

QIB*: 02.39X (*Excluding Anchor)
NII: 0.06X (Interest Cost ~235.01)
RII: 00.17X
Total: 0.78X

*RII Applications: 1.60L* Approx
No. of Applic-wise: 00.10X

QIB is subscribing, NII and Retail is avoiding ....

Face value plays important role in investor. HUL is famous company & have investor fancy in the market. But in this case company has not in the market so long, not known most of the people. Promoter are china based ,any political issue affect lot for the market. so comparison with HUL regarding price is not appropriate.

Investor fancy came from performance and creating brands. Have you seen performance number of this company in last 3 years.
Traded value can always be reduced by giving bonus and has little relevance. Many good companies which had split their share to Rs 1 went back to Rs 10 by reconsolidation.
In old time due to lot size this was an issue but when 1 share is trading lot how does it becomes an issue
Given the fact that this company's book value is Rs. 255 one can anticipate bonus to reduce optical illusion

primum 19/22